VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RNAC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
RNACCartesian Therapeutics, Inc.
$10.05$295M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRNACPrice History

RNAC logoCartesian Therapeutics, Inc. (RNAC) Stock Price History

Historical prices from 2016 to 2026

$10.05-0.29  (-2.80%)close Jul 7
Returns
1M
+71.5%
3M
+60.0%
YTD
+48.7%
1Y
-6.7%
3Y
-32.5%
5Y
-38.8%
ATH$840.00Nov 2016-98.8%
ATL$5.60Mar 2026pre-split
Avg Vol (50D)304K/ day
52-Week Range$5.60 — $15.57
LowCurrent: $10.05High

Loading 10-year price history...

RNAC Historical Performance

1 YearTotal Return
-6.7%
Price: -6.7%
3 YearsTotal Return
-69.3%
CAGR: -32.5%
Price: -69.3%
5 YearsTotal Return
-91.4%
CAGR: -38.8%
Price: -91.4%
YTD
+48.7%

RNAC Annual Returns

Year-by-year price performance · 2016–2026

Best+31.7%2020
Worst-74.0%2018
Up years4/11
2016+22.5%
2017-43.2%
2018-74.0%
2019-17.9%
2020+31.7%
2021+9.0%
2022-65.9%
2023-40.1%
2024-8.9%
2025-57.4%
2026+12.3%
2016 annual price return
+22.5%
2017 annual price return
-43.2%
2018 annual price return
-74.0%
2019 annual price return
-17.9%
2020 annual price return
+31.7%
2021 annual price return
+9.0%
2022 annual price return
-65.9%
2023 annual price return
-40.1%
2024 annual price return
-8.9%
2025 annual price return
-57.4%
2026 annual price return
+12.3%
LessMore
Alpha vs S&P 500
1Y-27.8%
3Y-53.3%
5Y-52.1%

Price returns only.

Download Historical Data

2,524 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

RNAC Stock Price Trajectory (2016–2026)

As of July 8, 2026, Cartesian Therapeutics, Inc. (RNAC) trades at $10.05, representing a -6.7% return over the past year. The stock has delivered a -91.4% total return over five years (-38.8% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $840.00 on November 28, 2016. From this peak, RNAC has corrected -98.8%, currently trading 30% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers KYMR (+172.2% 1Y), IMVT (+144.2% 1Y), and ARQT (+106.6% 1Y), RNAC has underperformed the peer group average. Compare RNAC vs KYMR →

RNAC Historical Price Data · from 2016

Rows 1–50 of 2,524
Date Open High Low Close Volume Change %
2026-07-0710.4210.609.7510.05138K-2.80%
2026-07-0610.6410.8310.2610.34124K-2.36%
2026-07-0210.3210.9110.0310.59177K+4.03%
2026-07-0110.3010.6210.1010.18149K-2.30%
2026-06-309.6510.609.2610.42526K+8.09%
2026-06-299.599.649.379.64185K+2.34%
2026-06-268.809.538.809.420+5.49%
2026-06-259.569.608.858.93247K-7.37%
2026-06-2410.4011.009.619.64189K-5.30%
2026-06-239.9410.809.9410.18293K+2.31%
2026-06-229.7510.299.609.95316K+3.32%
2026-06-1810.1010.399.489.63345K-2.53%
2026-06-179.0310.599.029.88602K+9.17%
2026-06-168.629.208.419.05368K+5.23%
2026-06-159.699.698.588.60259K-9.57%
2026-06-128.089.757.909.51873K+17.99%
2026-06-117.288.357.208.06507K+8.48%
2026-06-106.748.256.677.43540K+8.47%
2026-06-097.019.336.606.853.49M+16.89%
2026-06-086.006.305.835.86144K+0.34%
2026-06-056.476.715.775.84278K-10.84%
2026-06-046.326.976.326.5587K+4.55%
2026-06-036.436.616.176.26171K-2.26%
2026-06-026.907.056.306.41142K-7.37%
2026-06-017.357.626.826.92139K-8.22%
2026-05-297.457.607.047.54236K+4.58%
2026-05-286.837.336.837.21149K+4.04%
2026-05-276.487.006.466.93168K+7.44%
2026-05-266.877.376.046.45369K-4.44%
2026-05-226.747.056.506.75108K+1.05%
2026-05-216.426.836.216.68123K+2.45%
2026-05-206.106.806.106.52177K+7.06%
2026-05-197.077.076.066.09208K-11.61%
2026-05-187.337.646.746.89136K-6.64%
2026-05-158.218.217.347.38120K-10.76%
2026-05-148.498.598.248.2782K-1.78%
2026-05-138.738.758.278.42119K-3.22%
2026-05-128.368.868.368.70107K+1.99%
2026-05-118.609.238.508.53279K-1.39%
2026-05-088.218.698.208.65151K+6.00%
2026-05-078.078.227.928.16176K-2.16%
2026-05-067.468.407.388.34278K+12.86%
2026-05-057.017.466.837.39296K+6.64%
2026-05-046.217.006.216.93230K+11.41%
2026-05-016.206.425.956.22205K0.00%
2026-04-306.416.556.216.22117K-3.86%
2026-04-296.746.746.406.47157K-4.85%
2026-04-287.057.216.776.8094K-4.09%
2026-04-277.077.336.907.09232K+5.04%
2026-04-247.057.126.716.75118K-3.16%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

RNAC — Frequently Asked Questions

Quick answers to the most common questions about buying RNAC stock.

How has RNAC stock performed recently?

RNAC declined -6.7% over the past year, below its 5-year annualized CAGR of -38.8%. The stock trades above its 200-day moving average, reflecting the downtrend.

What is RNAC's all-time high price?

Cartesian Therapeutics, Inc. reached $840.00 on 2016-11-28. The 52-week high is $15.57. Current 1-year return of -6.7% places the stock further from historical peaks.

Where can I download RNAC historical price data?

This page provides RNAC daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2016-2026, downloadable in CSV format.

422 data points · sampled from 2,524